VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety and efficacy of vismodegib in patients aged =65 years with advanced basal cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and efficacy of vismodegib in patients aged =65 years with advanced basal cell carcinoma.
Safety and efficacy of vismodegib in patients aged =65 years with advanced basal cell carcinoma. Oncotarget. 2016 11 15; 7(46):76118-76124.
View in:
PubMed
subject areas
Age Factors
Aged
Aged, 80 and over
Anilides
Antineoplastic Agents
Carcinoma, Basal Cell
Combined Modality Therapy
Female
Hedgehog Proteins
Humans
Male
Middle Aged
Neoplasm Staging
Pyridines
Signal Transduction
Skin Neoplasms
Treatment Outcome
authors with profiles
MICHAEL R MIGDEN